Dpharma SRL
The score of Dpharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +37 % Total assets +13 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dpharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 26 Aug 2026
- Year ended 31 Dec 2024filed on 28 Aug 2025
- Year ended 31 Dec 2023filed on 29 Aug 2024
- Year ended 31 Dec 2022filed on 29 Aug 2023
- Year ended 31 Dec 2021filed on 28 Aug 2022
Dpharma's financial analysis
- Solvency68.8%sector median: 46.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dpharma
Dpharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0508.697.593
- VAT number
- BE0508697593
- Peppol
- Registered · 0208:0508697593 · as of 06 Nov 2026
- Legal form
- SRL
- Incorporated
- 24 Dec 2012
- Registered office
- 6687 Bastogne
- Latest accounts
- 2025 · filed on 26 Aug 2026
- Activity
- Activities of holding companies (NACE 64210)
Dpharma (SRL) has been based in Bastogne since 2012, active in: activities of holding companies. For 2025, it reports a net profit of 123,673 € and equity of €1.25m; its revenue is not published. Its solvency stands at 68.8%, above the median of its sector (46.9%).
Companies similar to Dpharma
Companies in the same business, of comparable size and area, outside its group.
- V.K.C. Activities of holding companies Bruges · balance sheet €1.04m
- Management Bollen Thierry Activities of holding companies Kortenberg · balance sheet €1.86m
- Interpan Activities of holding companies Roeselare · balance sheet €1.84m
- MC Real Estate Activities of holding companies Veurne · balance sheet €1.77m
- Aforis Activities of holding companies Antwerp · balance sheet €1.87m
- Vanthovest Activities of holding companies Koksijde · balance sheet €1.75m
- Omega B Activities of holding companies Antwerp · balance sheet €1.74m
- DG Works Activities of holding companies Sint-Martens-Latem · balance sheet €1.94m
Frequently asked questions about Dpharma
What is the revenue of Dpharma?
Dpharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dpharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0508697593 for Dpharma, if the company is VAT-registered. Its company number (CBE) is 0508.697.593.
Where is the registered office of Dpharma?
According to the CBE register, the registered office of Dpharma is in 6687 Bastogne.
What is the equity of Dpharma?
At the close of the 2025 financial year, the equity of Dpharma amounts to 1,250,087 €, a solvency of 68.8% of total assets.
Who manages Dpharma?
The register lists 1 active mandates at Dpharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Dpharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →